Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 30S ribosomal subunit of Helicobacter pylori is a fundamental component of the bacterial translation machinery, composed of the 16S ribosomal RNA (rRNA) and approximately 21 ribosomal proteins. Its primary biological function is to initiate protein synthesis by facilitating the correct pairing of mRNA codons with tRNA anticodons, ensuring high fidelity in the decoding of the genetic message (PubMed: 12453497). In clinical medicine, this subunit is a major therapeutic target for treating H. pylori infections, which are strongly linked to the development of peptic ulcers and gastric cancer (NIH: Helicobacter pylori and Cancer). Antibiotics such as tetracycline exert their bactericidal or bacteriostatic effects by binding to the 30S subunit and physically obstructing the entry of aminoacyl-tRNA into the A-site, thereby terminating protein production (StatPearls: Tetracycline). However, the efficacy of these treatments is increasingly threatened by the emergence of resistant strains harboring specific mutations in the 16S rRNA gene, such as the AGA926-928TTC triple substitution (PubMed: 15933035). Consequently, the 30S subunit remains a focal point for the surveillance of antibiotic resistance and the design of novel antimicrobial agents intended to overcome existing resistance mechanisms.
Inhibition of bacterial protein synthesis by binding to the 16S rRNA of the 30S subunit, which prevents the attachment of aminoacyl-tRNA to the ribosomal A-site and halts polypeptide chain elongation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 30S ribosomal subunit (Helicobacter pylori) (30S subunit).